A1ZN34:BVMF
AstraZeneca
R$139.90
0.00%
(0.00) 1D
Okt 16, 5:06:00 PM GMT-3 · BRL
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa A1ZN34...
Buksan
R$143.33
Mataas
R$143.33
Mababa
R$138.81
Mkt. cap
259.42B
Avg. na dami
892.00
Dami
1.25K
Mataas nang 52-wk
R$190.40
Mababa nang 52-wk
R$129.06
Mga natitirang share
1.55B
Bilang ng mga empleyado
96K
Buksan
R$143.33
Mataas
R$143.33
Mababa
R$138.81
Mkt. cap
259.42B
Avg. na dami
892.00
Dami
1.25K
Mataas nang 52-wk
R$190.40
Mababa nang 52-wk
R$129.06
Mga natitirang share
1.55B
Bilang ng mga empleyado
96K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
ad-hoc-news.de
·
5 oras ang nakalipas
AstraZeneca announces insitro collaboration as AstraZeneca stock trades at EUR 146.33
The Twelfth Magpie
·
2 araw ang nakalipas
While the market panics about the FTSE 100, Citi just raised its AstraZeneca target to £186
JournalArta
·
2 araw ang nakalipas
AstraZeneca Stock Analysis: Gains 3.24%, Testing Key Resistance
BioSpace
·
3 araw ang nakalipas
AstraZeneca bulks up MASH, cardio work in up to $1.5B AI partnership with insitro
Profile
AstraZeneca plc is a Swedish–British multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England. It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation.
The company was founded in 1999 through the merger of the Swedish Astra AB and the British Zeneca Group. Zeneca shareholders received 53.5% of the shares, while Astra shareholders received the remaining 46.5%. Its portfolio includes primary and speciality care, coverage for rare diseases, and a robust global presence across various regions. Since the merger it has been among the world's largest pharmaceutical companies and has made numerous corporate acquisitions, including Cambridge Antibody Technology, MedImmune, Spirogen and Definiens. It has its research and development concentrated in three strategic centres: Cambridge, England; Gothenburg, Sweden; and Gaithersburg, Maryland, US.
AstraZeneca traces its earliest corporate history to 1913, when Astra AB was formed by a large group of doctors and apothecaries in Södertälje. Wikipedia
Tungkol sa AstraZeneca
CEOPascal Soriot
Mga Empleyado96.1K
ItinatagAbr 6, 1999
HeadquartersCambridge, Cambridgeshire, United Kingdom
Sektor-
Websiteastrazeneca.com